Chime Financial, Inc. Class A Common Stock
CHYM
$28.62
-4.34%
Chime Financial, Inc. is a financial technology company that delivers digital banking services through its proprietary platform in partnership with third-party banks, offering spending accounts, liquidity solutions, credit-building tools, and savings products to primarily lower-to-middle-income U.S. consumers. As a branchless, fee-light neobank, Chime occupies a distinct position as a scaled disruptor in the U.S. consumer fintech landscape, competing with traditional banks and other digital-first platforms while relying on partner-bank infrastructure rather than its own charter. The current investor narrative centers on a sharp profitability inflection: after a loss-making 2025, Chime posted positive net income in Q1 2026 and the stock rallied sharply in August 2026 following Q2 earnings that showed a major swing toward profitability. However, the debate remains balanced by structural concerns over the company's dependence on partner banks and its exposure to lower-income consumers, which analysts flag as a key risk to the durability of its earnings trajectory.…
CHYM
Chime Financial, Inc. Class A Common Stock
$28.62
Related headlines
Investment Opinion: Should I buy CHYM Today?
The synthesized recommendation is Buy, based on the confirmed profitability inflection, accelerating revenue growth, and a strongly bullish analyst consensus with a $39.41 average target (29.9% upside). The core thesis is that Chime has crossed the threshold to sustainable GAAP profitability, and the market has not yet fully priced in the durability of this earnings power, as evidenced by the forward PE of 18.84 and PS of 4.36.
The supporting evidence is compelling: Q1 2026 revenue grew 24.8% YoY to $647.39 million; net income turned positive at $53.46 million (8.26% margin); gross margin remains exceptionally high at 87.81%; free cash flow was positive at $80.03 million; and the balance sheet is strong with a current ratio of 4.53 and debt-to-equity of just 0.096. The forward PE of 18.84 is reasonable for a company with this growth profile, and the PS ratio of 4.36 is near the low end of its historical range (down from 40.03 in Q4 2023). Analyst estimates for forward EPS of $3.14 and revenue of $4.86 billion imply continued momentum.
The biggest risks that could invalidate the thesis are: (1) a reversal in profitability if operating expenses reaccelerate, (2) regulatory or partner-bank disruptions, and (3) a consumer credit downturn affecting Chime's lower-income member base. The rating would upgrade to a stronger Buy if Q2 2026 confirms sequential margin expansion and revenue growth above 25%, or downgrade to Hold if net income turns negative again or revenue growth decelerates below 15%. Relative to its history and peers, the stock appears undervalued on a growth-adjusted basis, though the negative trailing metrics warrant caution.
Sign up to view all
CHYM 12-Month Price Forecast
Chime presents a compelling growth-at-a-reasonable-price opportunity, with the profitability inflection providing a clear catalyst for multiple expansion. The forward PE of 18.84 and PS of 4.36 are attractive for a company growing revenue nearly 25% with 87.8% gross margins. However, the recent 8.29% one-month decline and the unproven nature of the earnings turnaround warrant a medium confidence rating. I would upgrade to high confidence if Q2 2026 confirms sequential margin expansion and revenue growth above 25%, and downgrade to neutral if net income turns negative or revenue growth falls below 15%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Chime Financial, Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $39.41 and implied upside of +37.7% versus the current price.
Average Target
$39.41
0 analysts
Implied Upside
+37.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$30 - $50
Analyst target range
Chime is covered by 22 analysts with a consensus recommendation of "strong_buy" (recommendation mean of 1.43, where 1.0 is a strong buy), reflecting broad institutional optimism. The average price target is $39.41, which implies approximately 29.9% upside from the current price of $30.33, and the consensus leans decisively bullish. The estimated average EPS of $3.14 (range $3.00 to $3.35) and estimated average revenue of $4.86 billion (range $4.70 billion to $5.12 billion) underpin this optimism, suggesting analysts expect substantial profitability and continued top-line growth. The bullish consensus is notable given the stock's recent 8.29% one-month decline, implying analysts view the pullback as a buying opportunity rather than a deterioration in fundamentals. The target range spans $30.00 to $50.00, a wide spread that signals meaningful disagreement about the company's trajectory. The high target of $50.00 (65% above current) likely assumes successful scaling of the profitability inflection, multiple expansion as the market gains confidence in the forward PE of 18.84, and continued 20%+ revenue growth. The low target of $30.00 (essentially flat to current) prices in margin compression, competitive pressures, or disappointment on the partner-bank and lower-income consumer risk factors flagged in recent coverage. Institutional ratings show a constructive pattern: Compass Point upgraded to Buy from Neutral on April 13, 2026, and Goldman Sachs upgraded to Buy from Neutral on December 1, 2025, while Canaccord Genuity, Wells Fargo, Evercore ISI, Piper Sandler, and JP Morgan all maintain Buy/Overweight ratings. The absence of any recent downgrades, combined with the strong_buy consensus and the wide but upward-skewed target range, suggests analysts see the recent pullback as a temporary consolidation within a longer-term uptrend, though the $20 spread between low and high targets underscores that execution on profitability remains the key swing factor.
Bulls vs Bears: CHYM Investment Factors
The bull case currently has stronger evidence, anchored by a confirmed profitability inflection (Q1 2026 net income of $53.46 million), accelerating revenue growth (24.8% YoY), a fortress balance sheet (D/E of 0.096), and a strongly bullish analyst consensus (29.9% upside to average target). However, the bear case is not without merit: trailing margins remain deeply negative, the company depends on partner banks and lower-income consumers, and recent price momentum has cooled sharply (-8.29% in one month). The single most important tension is whether the Q1 2026 operating margin of 7.13% is sustainable or a one-time anomaly — if it proves durable, the stock likely re-rates toward the $39-$50 range; if it reverses, the already-compressed multiples could contract further.
Bullish
- Profitability inflection confirmed: Q1 2026 net income turned positive at $53.46 million (8.26% net margin), a dramatic swing from a $44.78 million loss in Q4 2025 and a $923.38 million loss in Q2 2025. This marks the first meaningful proof that Chime's scaled model can generate GAAP profits.
- Revenue growth accelerating sequentially: Revenue rose to $647.39 million in Q1 2026, up 24.8% YoY and up 8.6% sequentially from $596.36 million in Q4 2025. The consistent multi-quarter progression ($528M → $544M → $596M → $647M) demonstrates durable top-line momentum.
- Fortress balance sheet with low leverage: Debt-to-equity is just 0.096 and the current ratio is 4.53, providing substantial financial flexibility. Cash stood at $622.19 million at the end of Q1 2026, and free cash flow turned positive at $80.03 million.
- Analyst consensus strongly bullish: 22 analysts rate the stock a 'strong_buy' (mean 1.43) with an average target of $39.41, implying 29.9% upside from $30.33. The high target of $50.00 suggests 65% upside if the profitability inflection scales.
Bearish
- Trailing profitability still deeply negative: Despite the Q1 2026 profit, trailing operating margin is -47.56% and net margin is -46.18%, with a trailing EPS of -$0.11. The company has only one quarter of positive net income, making the inflection unproven.
- Partner-bank dependency is structural: Chime relies on third-party banks for its banking infrastructure, exposing it to regulatory and partner risk. Recent coverage explicitly flags this reliance as a key risk to the durability of its earnings trajectory.
- Exposure to lower-income consumers: Chime's core demographic is lower-to-middle-income U.S. consumers, making revenue highly sensitive to economic downturns and unemployment. This concentration amplifies credit and spending risk in a recession.
- Recent momentum has sharply cooled: The stock is down 8.29% over the past month versus a 0.96% decline in SPY, producing a relative strength of -7.33%. This deceleration follows a parabolic 72.33% three-month surge and could signal trend exhaustion.
CHYM Technical Analysis
Chime is in a powerful recovery uptrend, with the stock up 29.95% over the past year and 58.38% over six months, though the 1-year gain understates the magnitude of the move from its 52-week low of $15.88. At the current price of $30.33, the stock sits at roughly 77.5% of its 52-week range (low $15.88 to high $35.55), positioning it in the upper portion of its band but still about 14.7% below the high. This suggests the stock retains upside room to prior resistance while no longer offering the deep-value entry that existed near the lows, and the 45.31% maximum drawdown underscores how violent the prior decline was before this recovery. Recent momentum has cooled sharply: the stock is down 8.29% over the past month versus a 0.96% decline in SPY, producing a relative strength of -7.33% that signals meaningful short-term underperformance. This 1-month weakness diverges from the still-strong 3-month gain of 72.33% and 6-month gain of 58.38%, a classic deceleration pattern that often follows a parabolic advance (note the jump from $25.92 on August 5 to $31.25 on August 6) and can signal either a healthy consolidation or the early stages of a trend reversal. The 1-year relative strength of +14.94% versus SPY confirms longer-term outperformance, but the recent divergence warrants caution until momentum stabilizes. Key technical levels are defined by the 52-week high of $35.55 as resistance and the 52-week low of $15.88 as major support, with the recent September pullback from $34.55 (September 9) to $30.33 (September 18) establishing near-term support around the $30 psychological level. A breakout above $35.55 would confirm the uptrend's continuation and likely open a new leg higher, while a breakdown below $30 could accelerate toward the $25-$26 area that served as the August launchpad. With a beta not available in the provided data, volatility must be inferred from the 45.31% max drawdown and the 72.33% three-month surge, both of which imply substantially above-market risk and argue for disciplined position sizing.
Beta
—
—
Max Drawdown
-45.3%
Largest decline past year
52-Week Range
$16-$36
Price range past year
Annual Return
+14.3%
Cumulative gain past year
| Period | CHYM Return | S&P 500 |
|---|---|---|
| 1m | -12.7% | +1.0% |
| 3m | +64.7% | +5.5% |
| 6m | +61.2% | +19.9% |
| 1y | +14.3% | +16.0% |
| ytd | +8.4% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CHYM Fundamental Analysis
Chime's revenue trajectory is clearly accelerating: Q1 2026 revenue reached $647.39 million, up 24.8% year-over-year from $518.74 million in Q1 2025, and up sequentially from $596.36 million in Q4 2025 and $543.52 million in Q3 2025. The multi-quarter progression ($528.15M in Q2 2025, $543.52M in Q3 2025, $596.36M in Q4 2025, $647.39M in Q1 2026) shows consistent sequential growth, with the payments revenue segment contributing $432.64 million of the most recent quarter's total. This steady top-line expansion, combined with the 24.8% YoY growth rate, supports the investment case that Chime is scaling its member base and monetization effectively, though the single-segment disclosure limits visibility into which products are driving growth. Profitability has inflected decisively: Q1 2026 net income was $53.46 million (a positive 8.26% net margin) versus a loss of $44.78 million in Q4 2025 and a massive $923.38 million loss in Q2 2025, which was distorted by a $621.75 million R&D charge and $279.67 million in G&A. Gross margin remains exceptionally high at 87.81% in Q1 2026 (gross profit of $568.48 million), consistent with the 87-89% range across recent quarters, but the company's trailing operating margin is still -47.56% and net margin -46.18% due to the prior-year losses. The key question is whether the Q1 2026 operating margin of 7.13% is sustainable, given that selling and marketing expenses of $165.43 million and R&D of $109.78 million continue to consume a large share of revenue. The balance sheet is a source of strength: debt-to-equity is just 0.096, the current ratio is a robust 4.53, and cash at the end of Q1 2026 stood at $622.19 million. Free cash flow turned positive at $80.03 million in Q1 2026 (TTM FCF of $143.52 million), a dramatic improvement from -$31.39 million in Q1 2025, and operating cash flow of $87.48 million comfortably covers capital expenditures of just $7.45 million. However, ROE is deeply negative at -72.05% on a trailing basis, reflecting the prior losses and the equity structure, and the company repurchased $85.74 million of stock in Q1 2026, signaling management confidence in internal cash generation.
Quarterly Revenue
$647387000.0B
2026-03
Revenue YoY Growth
+24.8%
YoY Comparison
Gross Margin
87.8%
Latest Quarter
Free Cash Flow
$143518000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CHYM Overvalued?
Because Chime's trailing net income is negative (EPS of -$0.11, trailing PE of -9.43), the PE ratio is not meaningful as a primary metric; instead, the PS ratio of 4.36 and EV/Sales of 4.34 are the appropriate valuation anchors, supplemented by the forward PE of 18.84, which reflects the market's expectation of a sharp earnings inflection. The gap between the negative trailing PE and the positive forward PE of 18.84 is the single most important valuation signal here: it implies the market expects Chime to swing to meaningful profitability, consistent with the $3.14 average estimated EPS for the forward period. The forward PE of 18.84 is not demanding in absolute terms for a company growing revenue 24.8% YoY, suggesting the market is pricing in execution risk rather than euphoria. On a peer basis, the PS ratio of 4.36 compares favorably to the company's own historical PS ratios, which ranged from 11.04 in Q1 2026 to 40.03 in Q4 2023, indicating significant multiple compression even as the stock price has risen. Relative to the broader software-application sector, a 4.36x PS with 87.8% gross margins and 24.8% growth could be viewed as reasonable, though the negative net margin (-46.18% trailing) and the reliance on partner banks justify some discount to higher-quality fintech peers. The EV/EBITDA of -9.40 is negative and therefore not useful for comparison, reinforcing that PS and forward PE are the correct lenses. Historically, Chime's valuation has compressed dramatically: the PS ratio fell from 40.03 in Q4 2023 to 11.04 in Q1 2026 and now 4.36, while the PB ratio declined from 14.44 in Q1 2024 to 6.80 currently. This places the stock near the bottom of its own historical valuation band on both PS and PB, which could signal either a genuine value opportunity if profitability proves durable, or a market that remains skeptical of the sustainability of the Q1 2026 earnings inflection. The forward PE of 18.84 versus the trailing PE of -9.43 implies the market is pricing in a dramatic earnings recovery, and if that recovery disappoints, the stock could re-rate lower despite the already-compressed multiples.
PE
-9.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 33x~46x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-9.4x
Enterprise Value Multiple
Investment Risk Disclosure
Chime's financial risk profile is dominated by the unproven nature of its profitability inflection. While Q1 2026 net income was $53.46 million, the trailing operating margin is -47.56% and trailing net margin is -46.18%, reflecting the massive $923.38 million loss in Q2 2025. The company's ability to sustain positive earnings depends on maintaining high gross margins (87.81% in Q1 2026) while controlling operating expenses, which remain substantial at $522.32 million in Q1 2026. Additionally, the reliance on partner banks for core banking infrastructure creates operational and regulatory dependency risk that could disrupt services or increase costs.
Market and competitive risks are significant given Chime's premium valuation relative to its own history and the broader fintech landscape. The PS ratio of 4.36, while down from historical highs, still implies the market expects continued high growth and margin expansion. Competition from traditional banks, other neobanks, and fintech platforms could pressure member acquisition costs and monetization. The stock's recent 8.29% one-month decline and -7.33% relative strength versus SPY signal waning momentum, and with a 45.31% maximum drawdown, volatility is clearly elevated. Macro sensitivity is high because Chime's lower-income consumer base is disproportionately affected by inflation, unemployment, and interest rate changes.
The worst-case scenario involves a reversal of the profitability inflection combined with a deterioration in consumer credit conditions. If Q2 2026 earnings show a return to losses, the stock could quickly retest its 52-week low of $15.88, representing a 47.6% decline from the current price of $30.33. The analyst low target of $30.00 provides little downside cushion, and a break below the $30 psychological support could accelerate selling toward the $25-$26 August launchpad. In a severe recession, with rising unemployment among Chime's core demographic, revenue growth could stall and credit losses could mount, potentially driving the stock below $20.
FAQ
The most severe risk is the unproven profitability inflection: trailing operating margin is -47.56% and net margin is -46.18%, and a return to losses could quickly drive the stock toward its 52-week low of $15.88. Second, Chime's reliance on partner banks for banking infrastructure creates regulatory and operational dependency risk. Third, its exposure to lower-income consumers makes revenue highly sensitive to economic downturns and credit deterioration. Fourth, the stock has a history of extreme volatility, with a 45.31% maximum drawdown, and recent momentum has cooled (-8.29% in one month), which could signal a trend reversal.
The 12-month forecast is based on three scenarios: a bull case (30% probability) targeting $45-$50 if profitability scales and the market re-rates the stock; a base case (50% probability) targeting $35-$42, aligned with the analyst average of $39.41, assuming steady execution; and a bear case (20% probability) targeting $20-$30 if profitability reverses or consumer credit deteriorates. The base case is most likely, hinging on revenue growth of 20-25% and net margin stabilizing in the 5-10% range. The wide analyst target range of $30-$50 underscores the uncertainty, but the upward skew suggests a favorable risk/reward.
CHYM appears undervalued on a growth-adjusted basis. The forward PE of 18.84 is reasonable for a company growing revenue 24.8% YoY, and the PS ratio of 4.36 is near the low end of its historical range (down from 40.03 in Q4 2023). The EV/Sales of 4.34 and PB of 6.80 also reflect significant multiple compression. The market is pricing in execution risk rather than euphoria, as evidenced by the gap between the negative trailing PE of -9.43 and the positive forward PE of 18.84. If Chime sustains its profitability, the stock could re-rate toward the analyst average target of $39.41, implying 29.9% upside.
From a risk/reward perspective, CHYM offers a favorable setup with 29.9% upside to the analyst average target of $39.41, balanced against a potential 47.6% downside to the 52-week low of $15.88 in a bear scenario. The company just posted its first positive net income of $53.46 million in Q1 2026, and revenue is growing at 24.8% YoY, which supports the bull case. However, the stock is down 8.29% in the past month and trailing margins remain deeply negative, so the inflection is not yet proven. It is a good buy for growth-oriented investors who can tolerate volatility and have a 2-3 year horizon, but conservative investors may want to wait for Q2 2026 confirmation of sustained profitability.
CHYM is better suited for long-term investment with a minimum holding period of 2-3 years, given its early-stage profitability inflection and the need for multiple quarters of execution to validate the thesis. The stock's high volatility (45.31% max drawdown, 72.33% three-month surge) makes it risky for short-term trading, though momentum traders may find opportunities around earnings. The lack of a dividend (payout ratio 0%) means returns depend entirely on capital appreciation. Long-term investors can benefit from the digital banking disruption theme and the potential for significant multiple expansion if Chime proves sustainable profitability.